# Sportsman'S Warehouse Holdings, Inc.: financial statements, quarterly SPWH · Nasdaq · CIK 1132105 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Feb 1 Pages: [Overview](/companies/spwh.md) · [Financials](/companies/spwh/financials.md) · [Filings](/companies/spwh/filings.md) · [Insiders](/companies/spwh/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/spwh/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [341](/filings/0000950170-24-135215.md) | [370 d](/filings/0001193125-26-134702.md) | [244](/filings/0000950170-25-081405.md) | [289](/filings/0001132105-25-000005.md) | [324](/filings/0001193125-25-308111.md) | [340 d](/filings/0001193125-26-134702.md) | [249](/filings/0001193125-26-253546.md) | [294](/filings/0001193125-26-378442.md) | [331](/filings/0001193125-25-308111.md) | [335 d](/filings/0001193125-26-134702.md) | [256](/filings/0001193125-26-253546.md) | [296](/filings/0001193125-26-378442.md) | | Cost of revenue | $m | [237](/filings/0000950170-24-135215.md) | [271 d](/filings/0001193125-26-134702.md) | [170](/filings/0000950170-25-081405.md) | [199](/filings/0001132105-25-000005.md) | [221](/filings/0001193125-25-308111.md) | [237 d](/filings/0001193125-26-134702.md) | [173](/filings/0001193125-26-253546.md) | [200](/filings/0001193125-26-378442.md) | [223](/filings/0001193125-25-308111.md) | [240 d](/filings/0001193125-26-134702.md) | [180](/filings/0001193125-26-253546.md) | [200](/filings/0001193125-26-378442.md) | | Gross profit | $m | [103](/filings/0000950170-24-135215.md) | [99.4 d](/filings/0001193125-26-134702.md) | [73.8](/filings/0000950170-25-081405.md) | [90.0](/filings/0001132105-25-000005.md) | [103](/filings/0001193125-25-308111.md) | [104 d](/filings/0001193125-26-134702.md) | [75.6](/filings/0001193125-26-253546.md) | [93.9](/filings/0001193125-26-378442.md) | [109](/filings/0001193125-25-308111.md) | [95.2 d](/filings/0001193125-26-134702.md) | [75.8](/filings/0001193125-26-253546.md) | [96.0](/filings/0001193125-26-378442.md) | | Selling, general and administrative | $m | [100](/filings/0000950170-24-135215.md) | [107 d](/filings/0001193125-26-134702.md) | [94.4](/filings/0000950170-25-081405.md) | [94.3](/filings/0001132105-25-000005.md) | [100.0](/filings/0001193125-25-308111.md) | [100.0 d](/filings/0001193125-26-134702.md) | [95.3](/filings/0001193125-26-253546.md) | [97.2](/filings/0001193125-26-378442.md) | [104](/filings/0001193125-25-308111.md) | [96.2 d](/filings/0001193125-26-134702.md) | [93.9](/filings/0001193125-26-253546.md) | [97.1](/filings/0001193125-26-378442.md) | | Operating income | $m | [3.1](/filings/0000950170-24-135215.md) | [(7.9) d](/filings/0001193125-26-134702.md) | [(20.6)](/filings/0000950170-25-081405.md) | [(4.3)](/filings/0001132105-25-000005.md) | [3.1](/filings/0001193125-25-308111.md) | [3.6 d](/filings/0001193125-26-134702.md) | [(19.6)](/filings/0001193125-26-253546.md) | [(3.2)](/filings/0001193125-26-378442.md) | [4.3](/filings/0001193125-25-308111.md) | [(18.8) d](/filings/0001193125-26-134702.md) | [(18.1)](/filings/0001193125-26-253546.md) | [(1.1)](/filings/0001193125-26-378442.md) | | Interest expense | $m | [3.9](/filings/0000950170-24-135215.md) | [3.4 d](/filings/0001193125-26-134702.md) | [2.9](/filings/0000950170-25-081405.md) | [3.2](/filings/0001132105-25-000005.md) | [3.3](/filings/0001193125-25-308111.md) | [2.9 d](/filings/0001193125-26-134702.md) | [3.0](/filings/0001193125-26-253546.md) | [3.8](/filings/0001193125-26-378442.md) | [4.1](/filings/0001193125-25-308111.md) | [3.0 d](/filings/0001193125-26-134702.md) | [2.6](/filings/0001193125-26-253546.md) | [3.3](/filings/0001193125-26-378442.md) | | Income tax | $m | [0.5](/filings/0000950170-24-135215.md) | [(2.5) d](/filings/0001193125-26-134702.md) | [(5.5)](/filings/0000950170-25-081405.md) | [(2.1)](/filings/0001132105-25-000005.md) | [0.2](/filings/0001193125-25-308111.md) | [9.3 d](/filings/0001193125-26-134702.md) | [(1.3)](/filings/0001193125-26-253546.md) | [0.1](/filings/0001193125-26-378442.md) | [0.2](/filings/0001193125-25-308111.md) | [(0.1) d](/filings/0001193125-26-134702.md) | [1.0](/filings/0001193125-26-253546.md) | [(0.0)](/filings/0001193125-26-378442.md) | | Net income | $m | [(1.3)](/filings/0000950170-24-135215.md) | [(8.7) d](/filings/0001193125-26-134702.md) | [(18.1)](/filings/0000950170-25-081405.md) | [(5.9)](/filings/0001132105-25-000005.md) | [(0.4)](/filings/0001193125-25-308111.md) | [(8.7) d](/filings/0001193125-26-134702.md) | [(21.3)](/filings/0001193125-26-253546.md) | [(7.1)](/filings/0001193125-26-378442.md) | [0.0](/filings/0001193125-25-308111.md) | [(21.7) d](/filings/0001193125-26-134702.md) | [(21.8)](/filings/0001193125-26-253546.md) | [(4.4)](/filings/0001193125-26-378442.md) | | Diluted EPS | $ per share | [(0.04)](/filings/0000950170-24-135215.md) | not reported | [(0.48)](/filings/0000950170-25-081405.md) | [(0.16)](/filings/0001132105-25-000005.md) | [(0.01)](/filings/0001193125-25-308111.md) | not reported | [(0.56)](/filings/0001193125-26-253546.md) | [(0.18)](/filings/0001193125-26-378442.md) | [0.00](/filings/0001193125-25-308111.md) | not reported | [(0.56)](/filings/0001193125-26-253546.md) | [(0.11)](/filings/0001193125-26-378442.md) | | Basic EPS | $ per share | [(0.04)](/filings/0000950170-24-135215.md) | not reported | [(0.48)](/filings/0000950170-25-081405.md) | [(0.16)](/filings/0001132105-25-000005.md) | [(0.01)](/filings/0001193125-25-308111.md) | not reported | [(0.56)](/filings/0001193125-26-253546.md) | [(0.18)](/filings/0001193125-26-378442.md) | [0.00](/filings/0001193125-25-308111.md) | not reported | [(0.56)](/filings/0001193125-26-253546.md) | [(0.11)](/filings/0001193125-26-378442.md) | - Revenue: us-gaap:Revenues - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-10-28) | FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [2.9](/filings/0000950170-23-068686.md) | [3.1](/filings/0000950170-25-048890.md) | [2.2](/filings/0000950170-24-069083.md) | [2.6](/filings/0000950170-24-103115.md) | [2.7](/filings/0000950170-24-135215.md) | [2.8](/filings/0001193125-26-134702.md) | [3.6](/filings/0000950170-25-081405.md) | [1.8](/filings/0001132105-25-000005.md) | [2.2](/filings/0001193125-25-308111.md) | [1.7](/filings/0001193125-26-378442.md) | [2.1](/filings/0001193125-26-253546.md) | [2.0](/filings/0001193125-26-378442.md) | | Current assets | $m | [483](/filings/0000950170-23-068686.md) | [380](/filings/0000950170-25-048890.md) | [415](/filings/0000950170-24-069083.md) | [385](/filings/0000950170-24-103115.md) | [463](/filings/0000950170-24-135215.md) | [366](/filings/0001193125-26-134702.md) | [441](/filings/0000950170-25-081405.md) | [468](/filings/0001132105-25-000005.md) | [446](/filings/0001193125-25-308111.md) | [338](/filings/0001193125-26-378442.md) | [411](/filings/0001193125-26-253546.md) | [424](/filings/0001193125-26-378442.md) | | Total assets | $m | [980](/filings/0000950170-23-068686.md) | [886](/filings/0000950170-25-048890.md) | [930](/filings/0000950170-24-069083.md) | [902](/filings/0000950170-24-103115.md) | [968](/filings/0000950170-24-135215.md) | [852](/filings/0001193125-26-134702.md) | [930](/filings/0000950170-25-081405.md) | [949](/filings/0001132105-25-000005.md) | [914](/filings/0001193125-25-308111.md) | [763](/filings/0001193125-26-378442.md) | [838](/filings/0001193125-26-253546.md) | [836](/filings/0001193125-26-378442.md) | | Current liabilities | $m | [406](/filings/0000950170-23-068686.md) | [315](/filings/0000950170-25-048890.md) | [368](/filings/0000950170-24-069083.md) | [316](/filings/0000950170-24-103115.md) | [387](/filings/0000950170-24-135215.md) | [284](/filings/0001193125-26-134702.md) | [379](/filings/0000950170-25-081405.md) | [393](/filings/0001132105-25-000005.md) | [370](/filings/0001193125-25-308111.md) | [249](/filings/0001193125-26-378442.md) | [349](/filings/0001193125-26-253546.md) | [363](/filings/0001193125-26-378442.md) | | Total liabilities | $m | [708](/filings/0000950170-23-068686.md) | [622](/filings/0000950170-25-048890.md) | [683](/filings/0000950170-24-069083.md) | [659](/filings/0000950170-24-103115.md) | [724](/filings/0000950170-24-135215.md) | [616](/filings/0001193125-26-134702.md) | [715](/filings/0000950170-25-081405.md) | [740](/filings/0001132105-25-000005.md) | [704](/filings/0001193125-25-308111.md) | [574](/filings/0001193125-26-378442.md) | [671](/filings/0001193125-26-253546.md) | [672](/filings/0001193125-26-378442.md) | | Long-term debt | $m | not reported | [0.0](/filings/0000950170-25-048890.md) | not reported | [24.0](/filings/0000950170-24-103115.md) | [24.0](/filings/0000950170-24-135215.md) | [24.1](/filings/0001193125-26-134702.md) | [24.1](/filings/0000950170-25-081405.md) | [43.9](/filings/0001132105-25-000005.md) | [44.0](/filings/0001193125-25-308111.md) | [44.2](/filings/0001193125-26-378442.md) | [44.3](/filings/0001193125-26-253546.md) | [43.9](/filings/0001193125-26-378442.md) | | Current portion of debt | $m | not reported | not reported | not reported | [0.0](/filings/0000950170-24-103115.md) | [0.0](/filings/0000950170-24-135215.md) | [0.0](/filings/0001193125-26-134702.md) | [0.0](/filings/0000950170-25-081405.md) | [0.0](/filings/0001132105-25-000005.md) | [0.0](/filings/0001193125-25-308111.md) | [0.0](/filings/0001193125-26-378442.md) | [0.0](/filings/0001193125-26-253546.md) | [0.0](/filings/0001193125-26-378442.md) | | Shareholders' equity | $m | [272](/filings/0000950170-24-135215.md) | [265](/filings/0001193125-26-134702.md) | [248](/filings/0001132105-25-000005.md) | [243](/filings/0001193125-25-308111.md) | [244](/filings/0001193125-25-308111.md) | [236](/filings/0001193125-26-378442.md) | [215](/filings/0001193125-26-378442.md) | [209](/filings/0001193125-26-378442.md) | [210](/filings/0001193125-25-308111.md) | [189](/filings/0001193125-26-378442.md) | [167](/filings/0001193125-26-378442.md) | [164](/filings/0001193125-26-378442.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [41.7 d](/filings/0000950170-24-135215.md) | [68.9 d](/filings/0001193125-26-134702.md) | [(34.7)](/filings/0000950170-25-081405.md) | [18.5 d](/filings/0001132105-25-000005.md) | [(2.5) d](/filings/0001193125-25-308111.md) | [52.8 d](/filings/0001193125-26-134702.md) | [(60.2)](/filings/0001193125-26-253546.md) | [(26.6) d](/filings/0001193125-26-378442.md) | [16.3 d](/filings/0001193125-25-308111.md) | [102 d](/filings/0001193125-26-134702.md) | [(55.4)](/filings/0001193125-26-253546.md) | [(12.1) d](/filings/0001193125-26-378442.md) | | Capital expenditure | $m | [19.2 d](/filings/0000950170-24-135215.md) | [8.7 d](/filings/0001193125-26-134702.md) | [3.3](/filings/0000950170-25-081405.md) | [4.4 d](/filings/0001132105-25-000005.md) | [3.6 d](/filings/0001193125-25-308111.md) | [3.3 d](/filings/0001193125-26-134702.md) | [3.8](/filings/0001193125-26-253546.md) | [7.4 d](/filings/0001193125-26-378442.md) | [7.6 d](/filings/0001193125-25-308111.md) | [3.7 d](/filings/0001193125-26-134702.md) | [4.2](/filings/0001193125-26-253546.md) | [3.5 d](/filings/0001193125-26-378442.md) | | Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: not reported ## Shares | Line item | Unit | Q3 FY2022 (2022-10-29) | Q1 FY2023 (2023-04-29) | Q2 FY2023 (2023-07-29) | Q3 FY2023 (2023-10-28) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [38.7](/filings/0000950170-23-068686.md) | [37.6](/filings/0000950170-24-069083.md) | [37.5](/filings/0000950170-24-103115.md) | [37.4](/filings/0000950170-24-135215.md) | [37.6](/filings/0000950170-25-081405.md) | [37.8](/filings/0001132105-25-000005.md) | [37.9](/filings/0001193125-25-308111.md) | [38.1](/filings/0001193125-26-253546.md) | [38.4](/filings/0001193125-26-378442.md) | [39.2](/filings/0001193125-25-308111.md) | [38.8](/filings/0001193125-26-253546.md) | [39.0](/filings/0001193125-26-378442.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 39,141,465 at 2026-09-01, from the cover of the [10-Q filed 2026-09-01](/filings/0001193125-26-378442.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.